FDA Advisory Committees - FDA Center for Drug Evaluation and Research (CDER) - Psychopharmacologic Drug Advisory Committee (PDAC)

Upcoming Meetings

Past Meetings

Psychopharmacologic Drug Advisory Committee (PDAC)

PDAC reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the practice of psychiatry and related fields and makes appropriate recommendations to the Commissioner of Food and Drugs.

FDA Committee Website